Improve your experience. We are very sorry but this website does not support Internet Explorer. We recommend using a different browser that is supported such as Google Chrome or Mozilla Firefox.
Brent is the Vice President, Commercial & Franchise for Pacific Edge Limited (NZX: PEB) - a New Zealand publicly listed, cancer diagnostic company specialising in the discovery and commercialisation of diagnostic and prognostic technologies for the better detection and management of cancer. Brent has significant experience in the development, commercialisation, and strategic marketing of biologics and biomedical products in New Zealand, Australia, Asia and the United States.
Pacific Edge’s Cxbladder suite of non-invasive, simple to use and accurate diagnostic tests provide actionable results in the detection and management of urothelial cancer (UC). The company is developing and commercialising its range of Cxbladder bladder cancer tests globally through its wholly owned central laboratories in New Zealand and the USA and its products have been tested and validated in international multi-centre clinical studies.